Gene Logic's Revenues Tumble; Firm Continues to Mull Genomics Arm | GenomeWeb
NEW YORK (GenomeWeb News) — Gene Logic said today its first-quarter revenues fell 63 percent as R&D spending remained flat and net losses narrowed 17 percent.
 
Total receipts for the three months ended March 31 fell to $3.3 million from $8.7 million year over year.
 
All of the company’s revenue came from its genomics services business. Gene Logic reiterated that it has hired outside advisors to “assist in considering strategic alternatives” for its genomics business.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.